Apart from the AMPK pathway, emerging evidence has reported that metformin can also regulate AMPK-independent pathways, such as autophagy, oxidative stress and ER stress, to prevent retinal cells from vascular abnormalities, apoptosis, and cell senescence, which suppresses the development of diabetic retinopathy (DR). Here, PRKAA1 is linked to diabetic retinopathy.